ArticleArchives of Razi Institute2025
Antibacterial Photodynamic Therapy Using Zinc Phthalocyanine Against Multidrug-resistant
Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Due to the prevalence of MDR strains, alternative treatments such as antimicrobial photodynamic therapy (aPDT) have received much attention. This technique is an innovative technology that utilizes photosensitizers and generates active oxygen species. This study aimed to investigate the effectiveness of aPDT against multidrug-resistant (MDR) Materials & Methods: Optimization of PDT conditions -across different drug concentrations, different incubation times, different doses of laser radiation -was performed in vitro, and then the anti-biofilm effects of the optimal concentration against clinical isolates of MDR Results: Based on the results, the drug at a concentration of 40 µg/mL encapsulated in nanoemulsion, a laser dose of 13 J/cm Conclusion: The promising antibacterial and anti-biofilm activity of NE/ClZnlPc-mediated aPDT against MDR
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.